Rochelle Sampy is our resident Patients Editor.
Rochelle graduated from the University of Surrey with a 2.1 in Law with International Studies.
Previously Rochelle has written for Bauer Media and the South African newspaper and has contributed to the 7th edition CIPA Guide to the Patents Act by the Chartered Institute of Patent Attorneys as well as working for the European Healthcare Fraud and Corruption Network, Brussels.
Simon Davies, CEO of Teenage Cancer Trust talks about automatic patient enrollment into clinical trials.(Jun 11, 2012)
Following last week's announcement that new computer models have successfully predicted negative side effects in hundreds of current drugs, Rochelle Sampy asks whether computer modelling is any substitute for traditional patient trials...(Jun 20, 2012)
Pharmaceutical innovation or entrepreneurship must take priority over the wide distribution of cheaper drugs to ensure that all patients can benefit from an innovative healthcare system in the long run.(Jun 22, 2012)
Can GP’s take on the role of a ‘medical generalist’ or ‘expert in whole-person medicine’ within the NHS so as to improve standards for patients? Or should there just be better communication between healthcare providers across primary and secondary care in the NHS?(Jul 3, 2012)
The adoption of real world data in clinical practice to supplement or largely replace clinical trials will remove the challenges of demonstrating the value of medicines to patients, payers and healthcare providers.(Jul 13, 2012)
Big Pharma should rethink their price strategy for the emerging markets as they continue to develop their business overseas with countries like India.(Jul 16, 2012)
A recent Supreme Court of Texas ruling on drug safety liability, citing 'learned intermediary doctrine' leaves physicians open to litigation and patients out in the cold.(Jul 17, 2012)
The European Medicines Agency (EMA) puts patient safety and commercial interests first by giving independent researchers access to clinical trial data.(Jul 19, 2012)
The local pharmacist can empower patients to manage their own health and wellbeing thereby reducing the ever-increasing burden on other healthcare professionals.(Jul 24, 2012)
Can a collaborative attack by US health plan sponsors, policymakers and patients against Pharmacy Benefit Managers (PBMs) improve patient adherence?(Jul 26, 2012)
Petteri Jarkka, Customer Engagement Manager at Janssen Nordic, talks to eyeforpharma about how the...
New findings suggest that if recent steps taken by the CIS countries are seen through to completion...
EU citizens are unable to afford life-saving medication due to ongoing cuts and austerity measures...